Increasing Incidence of Thyroid Cancer in the Commonwealth of Pennsylvania

Abstract
Since the mid-1970s, the incidence of thyroid cancer in the United States has more than tripled,1-3 and thyroid cancer is now the seventh leading type of cancer in the nation.4 Moreover, by 2019, thyroid cancer is projected to become the third-most common cancer in women, with an annual age-adjusted incidence of 37 per 100 000.4 The majority of this increase is due to the rising incidence of papillary thyroid cancer (PTC), which is associated with an excellent prognosis and a 10-year survival rate of 95%.1,3,5,6 However, notwithstanding its favorable long-term survival, PTC still causes significant morbidity and poses significant clinical and economic burdens.4 Accordingly, thyroid cancer represents an increasingly important disease in the United States, although the reasons underlying the rapid rise in thyroid cancer remain enigmatic.